AI assistant
CASTLE BIOSCIENCES INC — Director's Dealing 2021
Jul 12, 2021
32601_dirs_2021-07-12_5e3c5958-7d2a-433d-bcb8-2044be3851cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-07-08
Reporting Person: BRADBURY DANIEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-08 | Common Stock | S | 700 | $68.362 | Disposed | 290293 | Indirect |
| 2021-07-08 | Common Stock | S | 1440 | $70.072 | Disposed | 288853 | Indirect |
| 2021-07-08 | Common Stock | S | 360 | $70.891 | Disposed | 288493 | Indirect |
| 2021-07-08 | Common Stock | S | 100 | $66.55 | Disposed | 157681 | Indirect |
| 2021-07-08 | Common Stock | S | 391 | $68.642 | Disposed | 157290 | Indirect |
| 2021-07-08 | Common Stock | S | 459 | $70.012 | Disposed | 156831 | Indirect |
| 2021-07-08 | Common Stock | S | 300 | $70.652 | Disposed | 156531 | Indirect |
| 2021-07-08 | Common Stock | S | 200 | $66.745 | Disposed | 157604 | Indirect |
| 2021-07-08 | Common Stock | S | 223 | $68.26 | Disposed | 157381 | Indirect |
| 2021-07-08 | Common Stock | S | 202 | $69.229 | Disposed | 157179 | Indirect |
| 2021-07-08 | Common Stock | S | 425 | $70.389 | Disposed | 156754 | Indirect |
| 2021-07-08 | Common Stock | S | 200 | $71.025 | Disposed | 156554 | Indirect |
| 2021-07-09 | Common Stock | S | 600 | $70.368 | Disposed | 287893 | Indirect |
| 2021-07-09 | Common Stock | S | 1800 | $72.261 | Disposed | 286093 | Indirect |
| 2021-07-09 | Common Stock | S | 100 | $72.76 | Disposed | 285993 | Indirect |
| 2021-07-09 | Common Stock | S | 846 | $73.171 | Disposed | 155685 | Indirect |
| 2021-07-09 | Common Stock | S | 404 | $73.806 | Disposed | 155281 | Indirect |
| 2021-07-09 | Common Stock | S | 1250 | $73.123 | Disposed | 155304 | Indirect |
Footnotes
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted collectively by BioBrit, LLC (the "LLC"), The Annette E. Bradbury Irrevocable Descendants' Trust, and The Daniel M. Bradbury Irrevocable Descendants' Trust on May 26, 2021.
F2: This transaction was executed in multiple trades at prices ranging from $67.870 to $68.680, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4: This transaction was executed in multiple trades at prices ranging from $69.630 to $70.450, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $70.720 to $71.015, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F7: This transaction was executed in multiple trades at prices ranging from $68.310 to $68.770, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8: This transaction was executed in multiple trades at prices ranging from $69.530 to $70.440, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9: This transaction was executed in multiple trades at prices ranging from $70.555 to $70.730, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F10: This transaction was executed in multiple trades at prices ranging from $66.530 to $66.950, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F11: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F12: This transaction was executed in multiple trades at prices ranging from $67.780 to $68.655, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F13: This transaction was executed in multiple trades at prices ranging from $68.785 to $69.580, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F14: This transaction was executed in multiple trades at prices ranging from $69.960 to $70.630, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F15: This transaction was executed in multiple trades at prices ranging from $71.015 to $71.035, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F16: This transaction was executed in multiple trades at prices ranging from $70.080 to $70.920, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F17: This transaction was executed in multiple trades at prices ranging from $71.730 to $72.660, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F18: This transaction was executed in multiple trades at prices ranging from $72.580 to $73.520, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F19: This transaction was executed in multiple trades at prices ranging from $73.580 to $74.050, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F20: This transaction was executed in multiple trades at prices ranging from $72.910 to $73.270, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.